As­traZeneca is chang­ing up dos­ing reg­i­mens of its check­point play­er in the face of the pan­dem­ic. The FDA ap­pears ready to make a quick as­sist

Faced with a stub­born glob­al pan­dem­ic, drug­mak­ers are look­ing to change up dos­ing reg­i­mens to re­duce the risk of ex­po­sure to Covid-19 dur­ing med­ical vis­its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.